🇺🇸 FDA
Patent

US 11844779

PKC-Delta-I inhibitor formulations and uses thereof

granted A61KA61K31/357A61K31/36

Quick answer

US patent 11844779 (PKC-Delta-I inhibitor formulations and uses thereof) held by United States Government as represented by the Department of Veterans Affairs expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/357, A61K31/36, A61K31/4035, A61K31/4184